1
Treatment options for chronic HBV infection have improved considerably in recent years.
2
We sought to investigate myocardial conditions in patients with chronic HBV infection.
3
Lifestyle intervention may be needed to halt the onset of steatosis in chronic HBV infection.
4
It showed those patients were not all in immune tolerant stage of chronic HBV infection.
5
The risk of dying prematurely because of chronic HBV infection is higher in younger people.
6
During the 20-year follow-up, no subject acquired new chronic HBV infection or clinical hepatitis B disease.
7
These data may provide useful information in both basic research and clinical treatment of chronic HBV infection.
8
Conclusions: Smoking contributed to more hepatocellular carcinomas in this Europe-wide cohort than chronic HBV and HCV infections.
9
However, precore mutants do not appear to have a detrimental effect on the course of chronic HBV infection.
10
Patients with HBeAg-negative chronic HBV infection may therefore be at particular risk when developing drug resistance to tenofovir.
11
The aim of the present study was to clarify the relationship between chronic HBV infection and NHL development.
12
Methods: A total of 213 patients with chronic HBV carriers diagnosed by clinical and liver biopsy were selected.
13
This study investigated the influence of CTLA-4 polymorphisms on disease susceptibility in Chinese Han patients with chronic HBV infection.
14
The present study investigated the relationships between the polymorphisms of the PD-1 gene and the susceptibility to chronic HBV infection.
15
Conclusions: In HIV-infected women, chronic HBV infection, mostly treated using targeted ART, had no major impact on the course of pregnancy.
16
Results show decreases in chronic HBV infection in most countries; no changes or increases in prevalence are noted in some African countries.
